ebook img

Asian Indian Phenotype PDF

14 Pages·2015·0.78 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Asian Indian Phenotype

RESEARCHARTICLE ‘ Circulating MiRNAs of Asian Indian ’ Phenotype Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes ParamasivamPrabu1,SophieRome2,ChandrakumarSathishkumar1, SankaramoorthyAravind1,BalakumarMahalingam1,Coimbatore SubramanianShanthirani1,CarolineGastebois2,AudreyVillard2,ViswanathanMohan1, MuthuswamyBalasubramanyam1* 1 MadrasDiabetesResearchFoundationandDr.Mohan’sDiabetesSpecialitiesCentre,WHOCollaborating CentreforNon-CommunicableDiseasesPreventionandControl&IDFCentreofEducation,Gopalapuram, Chennai-600086,India,2 CarMeNLaboratory(INSERM1060,INRA1397,INSA),UniversityofLyon, FacultédeMédecineLyon-Sud,CheminduGrandRevoyet,69600,Oullins,France * [email protected] OPENACCESS Citation:PrabuP,RomeS,SathishkumarC,Aravind Abstract S,MahalingamB,ShanthiraniCS,etal.(2015) CirculatingMiRNAsof‘AsianIndianPhenotype’ IdentifiedinSubjectswithImpairedGlucose Severalomicstechnologiesareunderwayworldwidewithanaimtounravelthepathophysi- ToleranceandPatientswithType2Diabetes.PLoS ologyofacomplexphenotypesuchastype2diabetesmellitus(T2DM).Whilerecentstud- ONE10(5):e0128372.doi:10.1371/journal. iesimplyaclinicallyrelevantandpotentialbiomarkerroleofcirculatorymiRNAsinthe pone.0128372 etiologyofT2DM,thereislackofdataonthisaspectinIndians—anethnicpopulationchar- AcademicEditor:RatnaB.Ray,SAINTLOUIS acterizedtorepresent‘AsianIndianphenotype’knowntobemorepronetodevelopT2DM UNIVERSITY,UNITEDSTATES andcardiovasculardiseasethanEuropeans.WeperformedglobalserummiRNAprofiling Received:February14,2015 andthevalidationofcandidatemiRNAsbyqRT-PCRinacohortofsubjectscomprisedof Accepted:April26,2015 normalglucosetolerance(NGT),impairedglucosetolerance(IGT)andpatientswithT2DM. Published:May28,2015 Ourstudyrevealed4differentiallyexpressedmiRNAs(miR-128,miR-130b-3p,miR-374a- 5p,miR-423-5p)insubjectswithIGTandT2DMpatientscomparedtocontrolsubjects. Copyright:©2015Prabuetal.Thisisanopen accessarticledistributedunderthetermsofthe Theywerepositivelyornegativelycorrelatedtocholesterollevels,HbA1C,HOMA-IRand CreativeCommonsAttributionLicense,whichpermits fastinginsulin.Interestingly,circulatinglevelofmiR-128andmiR-130b-3pwerealsoaltered unrestricteduse,distribution,andreproductioninany inserumofdiet-induceddiabeticmicecomparedtocontrolanimals.Amongthealteredcir- medium,providedtheoriginalauthorandsourceare culatingmiRNAs,miR-128hadneverbeendescribedinpreviousstudies/populationsand credited. appearedtobea‘NewLead’inIndians.Itwaspositivelycorrelatedwithcholesterolbothin DataAvailabilityStatement:Allrelevantdataare prediabeticsubjectsandindiet-induceddiabeticmice,suggestingthatitsincreasedlevel withinthepaperanditsSupportingInformationfiles. mightbeassociatedwiththedevelopmentofdyslipedemiaassociatedwithT2DM.Ourfind- Funding:Authorsacknowledgethefinancialsupport ingsimplydirectionalitytowardsbiomarkerpotentialofmiRNAsintheprevention/diagnosis/ fromtheDepartmentofBiotechnology(DBT), GovernmentofIndia.Thisworkwasalsosupported treatmentoutcomesofdiabetes. bygrantsfromtheFrenchFondationpourla RechercheMédicale(FRM-20101220456)andis supportedbytheFrench—Indianmedicalresearch cooperationprogrambetweenINSERMandICMR. Theauthorsthankthestudyparticipants,andthe clinicalassistantsandadministrativepersonnelatthe PLOSONE|DOI:10.1371/journal.pone.0128372 May28,2015 1/14 CirculatoryMiRNAsofAsianIndianPhenotype MadrasDiabetesResearchFoundation,Chennai, Introduction India. SouthAsiaformsoneoftheepicentersoftheglobaldiabetesepidemic.Overthepastcoupleof CompetingInterests:Theauthorshavedeclared decades,therehasbeenaworryingincreaseintheprevalenceratesoftype2diabetesmellitus thatnocompetinginterestsexist. (T2DM)intheregionandIndiainparticular.ThehigherprevalenceofdiabetesinSouth Asiansisleastexplainedbytraditionallymeasuredriskfactors.Insulinresistanceandabnor- malitiesofinsulinsecretioninpancreaticß-cellsarethemaindefectsthatleadtoT2DM.The socalled“AsianIndianPhenotype”referstocertainuniqueclinicalandbiochemicalabnormal- itiesinIndianswhichincludeincreasedinsulinresistance,greaterabdominaladiposityi.e., higherwaistcircumferencedespitelowerbodymassindexandT2DMoccurringatayounger agethanCaucasians[1,2].SouthAsiansarealsocharacterizedbyauniquemetabolicprofile withhigherinsulinlevels[3],agreaterdegreeofinsulinresistance[4]andahigherprevalence ofdiabetes[5].InsulinresistancehasbeendemonstratedinAsianIndiansevenduringadoles- cence[6]andhyperinsulinemiaseemstobepresentinAsianIndiansevenatbirth[7].Morere- centstudiesdoimplythatSouthAsiansmayhaveanearlydeclineinß-cellfunctionsaswell [8,9,2]. GiventhepredictedexplosioninthenumberofcasesofprediabetesandT2DMworldwide andinIndia,continuedresearchisessential,particularlyinthenewerareassuchasapplication ofmicroRNA(miRNA)technologies.MiRNAsareaclassofevolutionallyconservednon-cod- ingRNAsof19–22nucleotidesandfunctionasnegativeregulatorsofgeneexpression[10].Im- portantrolesofmiRNAshaveemergedinthecontrolofmetabolicpathwaysinvolvedinlipid metabolism,adipocytedifferentiationandpancreasdevelopment,energyhomeostasis,glucose- stimulatedinsulinsecretionandinflammation[11–16].Recently,significantamountsofmiR- NAshavebeenfoundnotonlyintracellularly,butinextracellularhumanbodyfluids(e.g.; serum,plasma,saliva,urine,tears,amnioticfluidsandmilk)[17–19].Theyareremarkablysta- bledespitehighextracellularRNAseactivities.ExtracellularmiRNAsareenclosedinsmall membranousvesicles(e.g.;inexosomes,sheddingvesicles,apoptoticbodies)orassociated with,orpackagedwithinhigh-densitylipoprotein,orassociatedwithRNA-bindingproteins(e. g.;high-densitylipoprotein,Argonaute2andnucleophosmin1)[20–22].LevelsofmiRNAsin theserumofhumanshavebeenshowntobestable,reproducible,consistentamongsthealthy individualsandchangeduringpathophysiology,allowingthemtobeofpotentialvalueasbio- markersofdisease[23].Recently,novelcirculatorymiRNAsignatureshavebeenstudiedand shownassociatednotonlywiththediseasebutalsotheseverityofdiseasessuchasvariouscan- cers,liverandcardiovasculardiseases[24,25].Whereasseveralstudieshaveevaluatedtherole ofmiRNAsincancer,muchlessisknowninthefieldofdiabetes.Differentiallyexpressedcircu- latorymiRNAsignaturecharacteristicofT2DMhavebeenreportedfromrecentstudiesout- sidetheIndiabasedontheanalysisofsmallgroupofsubjects[26–33].Fromthesestudies,itis expectedthattheidentificationofpotential-specificbiomarkersofmiRNAsmayhelppredict ordetectthedevelopmentandprogressionofdiabetesanditscomplicationsatanearlystage, andthereforeallowtimelyintervention.However,thereislackofclinicallyrelevantdataonthe potentialofcirculatorymiRNAsinIndians,whoarehighlyinsulinresistantandmoreproneto developT2DMandcardiovasculardiseasethanEuropeans[5].Whilethehealthburdenof T2DMissomehowassociatedwithobesityasaco-morbidityinCaucasians,metabolicriskfac- torsareeitherhigherinAsianIndiansindependentofobesityoroperateatalowerBMIthresh- old.Therefore,thisstudyisaimedtoidentifycirculatingmiRNAsthatcouldbedifferentially expressedinsubjectswithprediabetesandpatientswithT2DMandtodissectouttheirpoten- tialbiomarkersroleinassociationwithclinicalparameters/conventionalriskfactorsofT2DM. PLOSONE|DOI:10.1371/journal.pone.0128372 May28,2015 2/14 CirculatoryMiRNAsofAsianIndianPhenotype ResearchDesignandMethods RecruitmentoftheStudySubjects SubjectswithNGT(NormalGlucoseTolerance,n=49),subjectswithIGT(ImpairedGlucose Tolerance,n=47)andpatientswithType2DiabetesMellitus(T2DM,n=49)wererecruited fromDr.Mohans’DiabetesSpecialitiesCentre,Chennaiandfromtheon-goingepidemilogical studies.ThestudywasconductedaccordingtotheprinciplesofDeclarationofHelsinkiandap- propriateapprovalbytheInstitutionalEthicsCommitteeoftheMadrasDiabetesResearch Foundation.EthicsCommitteeapprovedwritteninformedconsentwasobtainedfromall studysubjects.NGT,IGTandT2DMweredefinedusingWorldHealthOrganizationconsult- inggroupcriteria.Thosewhowereconfirmedbyoralglucosetolerancetesttohave2-hour plasmaglucosevalue11.1mmol/L(200mg/dL)ormorebasedonWorldHealthOrganization consultinggroupcriteriawerediagnosedasdiabeticpatients.Thosewith2-hourpostglucose value(cid:1)7.8mmol/L(140mg/dL)and<11.1mmol/L(200mg/dL)werediagnosedassubjects withIGT,andthosewith2-hourpostglucosevalueoflessthan7.8mmol/L(140mg/dL)as subjectswithNGT.Toruleoutthemedicationeffects,allourT2DMsubjectsareofnewly diagnosednature. AnthropometricMeasurements Anthropometricmeasurementsincludingheight,weightandwaistcircumstancewereobtained usingstandardizedtechniques.Heightwasnotedwithatapemeasuredtothenearestcentime- ter.Weightwasmeasuredwithtraditionalspringbalancethatwaskeptonafirmhorizontal surface.Thebodymassindex(BMI)wascalculatedusingtheformula,weight(kg)/height(m)2. Waistcircumferencewasmeasuredusinganonstretchablefibermeasuringtape.Bloodpres- surewasrecordedfromtherightarmofstudysubjectswhentheywererelaxedandinsitting positiontothenearest2mmHgwithamercurysphygmomanometer(DiamondDeluxeBPap- paratus,Pune,India).Tworeadingweretaken5minapartandthemeanofthetwowastaken asthebloodpressure. BiochemicalParameterInvestigations Fastingplasmaglucose(glucoseoxidase-peroxidasemethod),serumcholesterol(cholesterol oxidase-peroxidase-amidopyrinemethod),serumtriglycerides(glycerolphosphateoxidase- peroxidase-amidopyrinemethod)andHDLcholesterol(directmethod-polyethyleneglycol- pretreatedenzymes)weremeasuredusingHitachi-912Autoanalyser(Hitachi,Mannheim, Germany).Theintraandinterassayco-efficientofvariationforthebiochemicalassayswere <5%.Low-densitylipoprotein(LDL)cholesterolwascalculatedusingFriedewaldformula. Glycatedhemoglobin(HbAlc)wasestimatedbyhigh-pressureliquidchromatographyusing thevariantanalyzer(Bio-Rad,Hercules,Calif.,USA).SerumInsulinwasestimatedusingen- zyme-linkedimmunosorbentassay(Calbiotech,CA).Theintra-assayandtheinter-assaycoef- ficientsofvariationforinsulinassaywas<10%.Insulinresistancewascalculatedusingthe homeostasisassessmentmodel(HOMA-IR)usingtheformula:{fastinginsulin(μIU/mL)x fastingglucose(mmol/L)}/22.5. CirculatingRNAExtractionandPurification Fastingserumsample(from5mlofblood)wasobtainedbystandardvenepunctureusing VacutainerPlusPlasticSerumandSSTTubes(Becton-Dickinson,Franklin,lakes,NJ).Thesep- arationoftheserumwasperformedbycentrifugationat4,000rpmfor10min,followedby 12000rpmfor15mintocompletelyremovecelldebris.TotalRNAwasisolatedfrom0.25ml PLOSONE|DOI:10.1371/journal.pone.0128372 May28,2015 3/14 CirculatoryMiRNAsofAsianIndianPhenotype Table1. Clinicalandbiochemicalcharacteristicsofthesubjectsinvolvedinthestudy. Wholecohort Subgroupofsubjectsusedtoselectcandidate miRNAs Parameters NGT IGT T2DM NGT IGT T2DM (n=49) (n=47) (n=49) (n=12) (n=12) (n=12) Males/females (26/23) (23/24) (25/24) (6/6) (6/6) (5/7) Age(years) 44.3±6.9 44.1±7.0 44.4±8.1 38.5±3.0 41.2±4.0 40.2±5.0 BMI(kg/m2) 24.5±2.6 24.9±2.9 25.7±3.5 23.1±2.0 23.9±1.0 26.7±1.0 Fastingplasmaglucose(mg/dl) 85±11 105±18* 146±34* 83±7.0 101±7.0* 150±27* 2hrplasmaglucose(mg/dl) 96±21 166±18* 269±63* 89±24 160±20* 264±61* HbA1c(%) 5.6±0.4 6.3±0.8* 7.8±1.6* 5.2±0.5 6.0±0.5 7.9±±1.0* HOMA-IR 2.0±1.1 3.5±1.4* 6.3±1.8* 1.5±0.4 2.7±1.0 5.0±3.0* SerumCholesterol(mg/dl) 170±24 187±35 185±52 168±29 185±39 185±52 SerumTriglycerides(mg/dl) 97±38 148±76 136±62 119±65 134±69 148±67 HDLcholesterol(mg/dl) 41.2±9.0 40±5.0 37±7.0 41±9.0 41±10 40±8.0 LDLcholesterol(mg/dl) 111±22 117±32 121±46 107±26 117±33 115±44 VLDL(mg/dl) 19±7.6 30±16 25±13 24±13 27±14 29±13 FastingInsulin(μIU/ml) 7.6±2.0 11±4.0 13±6.7 9.6±4.6 13.4±4.6* 17.8±4.0* Systolicbloodpressure(mmHg) 117±9.0 121±12 124±12 123±20 124±12 126±16 Diastolicbloodpressure(mmHg) 78±10 82±5.0 81±7.0 80±10 80±8.0 84±9 Waistcircumference(cm) 87.1±1.21 93.8±1.60* 92.3±1.38* 87.3±8.4 93.5±10.9* 92.3±9.6* Allthevaluerepresentsmeanand±standarddeviation *p<0.05comparedcontrol ND,notdetermined doi:10.1371/journal.pone.0128372.t001 ofserumusingQiagenmiRNeasyMinikit(Qiagen,Valencia,CA)forRNAcollectionandpu- rificationaccordingtothemanufacturer'sprotocol.TotalRNAwascontrolledusingNanodrop 2000UVspectrophotometerandstoredat-80°Cuntiluse. GlobalSerummicroRNAProfiling GlobalserummiRNAprofilingwasdoneinadiscoverycohortcomprisedof12individuals eachofNGT,IGTandT2DM(Table1).ToassesshemolysistwomicroRNAswereused.One thatisexpressedinredbloodcells(miRNA-451),andonethatisrelativelystableinserumand plasmaandnotaffectedbyhemolysis(miRNA-23a).TheratiobetweenthesetwomiRNAscor- relatestodegreeofhemolysis.Inourexperiencesampleswithratiosabove8.0willhaveanin- creasedriskofbeingaffectedbyhemolysis.Wevalidatedthatoursampleshadlowerratiosand werenotaffectedbyhemolysis.DuetothelowlevelsofmicroRNAsandpotentiallyhighlevels ofinhibitorsinsamplesderivedfromserum/plasmawhichalsodiffersfromsampletosample, Exiqonprotocol(www.exiqon.com/serum-plasma-guidelines)recommendsusingRNA amountsbasedonstartingvolumeratherthanRNAquantity.8μLofelutedhumanplasma/ serumRNAina40μLRTreactiongenerallygiveagoodsignalwithmaximalmiRNAdetection inmiRNAPCRpanels[34].Thereforeinourstudy,8μlRNAwasreversetranscribedin40μl reactionsusingthemiRCURYLNAUniversalRTmicroRNAPCRcDNAsynthesiskit.An RNAspike-incontrol(Sp6)wasaddedtothereversetranscriptionstep.Thiscontrolisusedto confirmthatthereversetranscriptionandamplificationoccurswithequalefficiencyinallsam- ples.cDNAwasdiluted50xandassayedin10μlPCRreactionsaccordingtotheprotocolfor miRCURYLNAUniversalRTmicroRNAPCR;eachmicroRNAwasassayedoncebyqPCRon PLOSONE|DOI:10.1371/journal.pone.0128372 May28,2015 4/14 CirculatoryMiRNAsofAsianIndianPhenotype themicroRNAReady-to-UsePCR(miRCURYLNAmicroRNAHumanpanelIExiqon).Neg- ativecontrolsexcludingtemplatefromthereversetranscriptionreactionwasperformedand profiledlikethesamples.TheamplificationwasperformedinaLightCycler480Real-Time PCRSystem(Roche)in384wellplates.Theamplificationcurveswereanalyzedusingthe RocheLCsoftware,bothfordeterminationofCp(bythe2ndderivativemethod)andformelt- ingcurveanalysis.AmplificationefficiencywascalculatedusingalgorithmssimilartotheLin- Regsoftware.AllassayswereinspectedfordistinctmeltingcurvesandtheTmwascheckedto bewithinknownspecificationsfortheassay.Furthermoreassaysmustbedetectedwith5Cp’s lessthanthenegativecontrol,andwithCp<37tobeincludedinthedataanalysis.Datathat didnotpassthesecriteriawereomittedfromanyfurtheranalysis.UsingNormFinderthebest normalizationprocedurewasfoundtobetheaverageofassaysdetectedinallsamples.Alldata werenormalizedtotheaverageofassaysdetectedinallsamples(average—assayCp).Compari- sonbetweengroupsweremadebyusingthestudentt-test(p<0.05)onnormalizeddata,tose- lectthedifferentiallyexpressedmiRNAs. ValidationofcandidatemiRNAsbyindividualqRT-PCR miRNAsshortlistedasdifferentiallyexpressedfromthediscoverysetwererevalidatedina largercohortcomprisingof145individuals(50%men,50%women)withNGT(n=49),IGT (n=47)andT2DM(n=49)byindividualPCRassays.TotalRNAfromserumwasextracted asdescribedaboveandusedforqRT-PCRbyusingtheUniversalmiRCURYLNAmicroRNA PCR,PolyadenylationandcDNAsynthesiskitIIandthemiRCURYLNAmicroRNAPCRsys- tem,ExilentSYBRgreenmastermix,fromExiqon,onABI7000AppliedBiosystemsthermo- cycler.RelativeexpressionofmicroRNAexpressionwascalculatedby2ˆ(-"DeltaCt")method.We evaluatedasuitablenumberofreferencemiRNAs,basedontheincreasedexpressionstability [28].However,wewereunabletoidentifystablemiRNAsthatdidnotdiscriminatebetween maleandfemaleorthatwerenotcorrelatedwithmetabolicparameters,orthatwasnotprevi- ouslyidentifiedasrelevantforthepathologyinpreviousstudies.Thiscouldbeexplainedpartly bythefactthatinsidethesamegroup,womenandmenmightdifferedintheirlevelofcholes- terolandtriglycerides(S1Table).Thus,inthisstudy,datawerenormalisedonthevolumeof totalRNAthatwasusedforqRT-PCR(i.e.;afixedvolumeof8μl). StatisticalMethods StatisticalanalyseswereperformedwiththeSPSSstatisticalsoftware(SPSSV12.0,Inc.,Chi- cago,IL),andtheRStatisticalSoftware(http://www.r-project.org/).ANOVAand/orpairedt- testswereperformedtostudydifferencesonquantitativevariablesbetweengroups. BioinformaticAnalysis CellularpathwaydeterminationforeachmiRNAwasdonebyusingDIANA-miRPath(http:// diana.imis.athena-innovation.gr/DianaTools/index.php?r=site/index)whichpredicted targetgenes. AnimalsMaintenance,PreclinicalCharacterizationandmiRNAProfiling MaleC57BL/6Jmice,10–12weeksold(bodyweight,18–22g)wereobtainedfromSriVenka- teswaraEnterprises(Bangalore)andmaintainedat22±1°Cundera12-hlight-darkcycle(lights onfrom6:00AMto6:00PM).Allexperimentswereperformedinaccordancewithregulations specifiedbytheCommitteeforthePurposeofControlandSupervisiononExperimentsonAn- imals(CPCSEA),GovernmentofIndiaandapprovalbytheInstitutionalAnimalEthical PLOSONE|DOI:10.1371/journal.pone.0128372 May28,2015 5/14 CirculatoryMiRNAsofAsianIndianPhenotype Committee(IAEC)oftheMadrasDiabetesResearchFoundationChennai.Food(Nutrilab, Bangalore)andwaterweregivenadlibitumtotheanimals.Highfatdiet(57%)wasprocured fromtheNationalInstituteofNutrition,Hyderabad,India.Afteracclimatization,basalfasting plasma/serumbiochemicalmarkerswereestimated.Micewererandomlydividedintotwo groupsi.e.,micefedwithnormalpelletdiet(NPD;n=5)andmicefedwithhighfatdiet(HFD; n=6),withsimilaraveragebodyweightandplasmaglucoseonday0.Allgroupswerefedwith respectivedietandwateradlibitumfor6months.Allbiochemicalandpreclinicalmeasure- mentsweredoneasperthestandardprocedures(S2Table).Attheendoftheprotocol,HFD fedanimalswerecharacterizedasglucose-intolerantandinsulin-resistantbyOGTT(OralGlu- coseToleranceTest)andITT(InsulinToleranceTest),respectively.Serumsamples(0.25ml) wereusedtoquantifycandidatemiRNAbyqRT-PCRaspreviouslydescribed. Results Inthisstudy,wehaveanalysedtheexpressionofcirculatingmicroRNAsinserumof145non obesesubjects(50%malesand50%females)sufferingfromT2DM(n=49)comparedwith controls(n=49)orpre-diabeticsubjects(n=47).AsshownonTable1,bothprediabetics (IGT)andpatientswithtype2diabetes(T2DM)hadpoorglycemiccontrolasreflectedbysig- nificanthigherfastingplasmaglucoseand2hrplasmaglucoseandhigherHbA valuescom- 1c paredwithcontrols.Subjectswithprediabetesandpatientswithtype2diabetesexhibited significantlyhigherinsulinresistanceasrevealedbyHOMA-IRestimation.Thelipidlevelsand bloodpressuredidnotsignificantlydifferamongthe3groups. ProfilingofCirculatingmiRNA SerummiRNAprofilingwasfirstperformedonasubgroupof36subjectsfromthe145subjects (50%malesand50%females).T2DMandIGTpatientsofthisidentificationsampleonlydif- feredclinicallyfromcontrolsubjectsinfastingglucoseand2hrplasmaglucoseandinfasting insulin.BothT2DMandIGTpatientshadsignificantlyhigherwaistcircumferencethanthe controlgroupofsubjects(Table1).TheglobalserummiRNAprofiling(miRCURYLNA microRNAHumanpanelIV3-Exiqon)detectedanaverageof~159miRNAspersampleof which112miRNAsweredetectedinallgroups.AsshownonS1Fig,themajorityofthe112 miRNAswereexpressedinasimilarwayandhierarchicalclusteringofthedatadidnotpermit todiscriminatebetweenthe3groups.Statisticaldataanalysisrevealedthatthemeanexpres- sionlevelof9miRNAs(i.e.;miR-128,miR-99b-5p,miR-130b-3p,miR-142-3p,miR-374a-5p, miR-423-5p,miR-484,miR-629-5p,let-7d-3p)wassignificantlydifferent(studentt-test p<0.05)acrossthestudiedgroups(Table2).TwomiRNAs(i.e.;miR-128andmiR-99b-5p) hadincreasedcirculatingconcentrationsbothinprediabeticsubjectsandpatientswithtype2 diabetescomparedtocontrolsubjects(Table2). Allthe9miRNAsdifferentiallyexpressedamongthediscoverygroupswereanalysedby quantitativeRT-PCRusingthewholecohortof145individuals(Fig1)containing50%men and50%women.AsshownonFig1,alteredexpressionsofmiR-128andmiR-423-5pinpre- diabeticpatientscomparedtocontrolswereconfirmedwithhighsignificance(p<0.05).Inad- dition,miR-374a-5pandmiR-130b-3pwerealteredinthesamedirectioninthewholegroup ofpatientssufferingfromT2DMthanindiscoverygroup,comparedtothecontrolgroupof subjects,andmiR-130b-3pwasonlyaffectedintheT2DMgroup.AlteredexpressionsofmiR- 629a-5p,let-7d-3p,miR-142-3pandmiR-484werenotconfirmedinthewholecohort (p<0.05). ThenmiRNAexpressionswereanalysedinwomenandmenindependently(Fig2).Altered expressionsofmiR-128inpre-diabeticstatevscontrolwasfoundsignificantinthegroupof PLOSONE|DOI:10.1371/journal.pone.0128372 May28,2015 6/14 CirculatoryMiRNAsofAsianIndianPhenotype Table2. ListofdifferentiallyexpressedcirculatingmiRNAsintheidentificationgroup. Groups miRNAs Foldchanges pvalue NGTvsIGT hsa-miR-128 1.42 0.041 hsa-miR-99b-5p 1.41 0.028 IGTvsT2DM hsa-miR-130b-3p 1.41 0.035 hsa-miR-142-3p 0.57 0.0041 hsa-miR-374a-5p 0.58 0.039 hsa-miR-423-5p 1.54 0.011 hsa-miR-484 1.37 0.004 hsa-miR-629-5p 1.84 0.030 NGTvsT2DM hsa-let-7d-3p 1.26 0.029 hsa-miR-128 1.50 0.047 hsa-miR-130b-3p 1.46 0.049 hsa-miR-142-3p 0.65 0.039 Ctvalueswereusedtoevaluatedifferencesamongtheidentificationgroupandtoselectcandidate miRNAs doi:10.1371/journal.pone.0128372.t002 womenonly.Onthecontrary,alteredexpressionofmiR-423-5pwassignificantlydecreased inthegroupofmen(NGTvsIGT)only.TheincreaselevelofmiR-374a-5pinthediabetic Fig1.CirculatingmiRNAconcentrationofthe9selectedmiRNAs,inthewholecohortof145 individuals.**=pvalues<0.05.Dataareexpressedasarbitraryunits(AU). doi:10.1371/journal.pone.0128372.g001 PLOSONE|DOI:10.1371/journal.pone.0128372 May28,2015 7/14 CirculatoryMiRNAsofAsianIndianPhenotype Fig2.CirculatingmiRNAconcentrationsofthe9selectedmiRNAs,inthewholecohortof145 individuals,butconsideringmen(M)andwomen(F)independently.**=pvalues<0.05.Dataare expressedasarbitraryunits(AU).Black,controlsubjects;Grey,pre-diabeticsubjects;White, diabeticpatients. doi:10.1371/journal.pone.0128372.g002 subjectsvscontrolswasfoundsignificantinthegroupofwomenonly.Finally,miR-142-3p whichwasnotdifferentiallyexpressedconsideringthewholecohort(Fig1),wasfounddiffer- entlyexpressedwhenthegroupofwomenwasanalysedindependently(NGTvsIGT,Fig2). CorrelationofmiRNAswithMetabolicParameters CorrelationsbetweenthelevelsofthevalidatedmiRNAswiththemetabolicparameterswere calculatedinthewholecohortofsubjects(Table3).Theywerepositivelyornegativelycorrelat- edtocholesterollevels,HbA ,insulinresistanceandhyperinsulinemia.MiR-128,whichwas 1C increasedinprediabeticpatients(Fig1),waspositivelycorrelatedwithserumcholesterol.On thecontrary,miR-423-5pdecreasedintheserumofprediabeticpatients(Fig1)wasnegatively correlatedtoHDL-cholesterol. miRNATargetGenesAnalysis Targetgenesofthe4validatedmiRNAswerepredictedandsignificantcellularpathwaysaffect- edbythesegeneswereretrievedforeachmiRNA.SignificantKEGGpathwaysareshownon Fig3.Therearerelatedtocellcycle,signalingpathways,lipidmetabolism,glycanbiosynthesis, brainfunctionsandimmunesystem. CirculatorymiRNAlevelsinHFDmicevsNPDfedmice Tofurthercorroboratetheassociationsassessedinhuman,thepresentstudyalsoanalyzedby meansofqRT-PCRcirculatingmiRNAconcentrationsintheplasmaofdiet-induceddiabetic mice(HFD).Inthecontextofthewell-knowninsulin-resistanceeffects,high-fatdietledto PLOSONE|DOI:10.1371/journal.pone.0128372 May28,2015 8/14 CirculatoryMiRNAsofAsianIndianPhenotype Table3. CorrelationsbetweencirculatingmiRNAconcentrationsandmetabolicparametersinthestudysubjects. miRNAs Metabolicparameters Estimate StdErr tValue Probt Correlationsnotadjustedforsex miR-128 Serum-cholesterol 0.003482 0.001333 2.61 0.0099 miR-423-5p HDL-cholesterol -0.3067 0.1363 -2.25 0.0260 miR-130b-3p HbA1C 0.1902 0.04745 4.01 <.0001 miR-374a-5p HbA1C 0.1745 0.07149 2.44 0.0159 miR-374a-5p HOMA-IR 0.1093 0.04364 2.50 0.0134 miR-374a-5p Fasting-Insulin 0.04148 0.01844 2.25 0.0260 miR-128 Serum-cholesterol 0.003594 0.001323 2.72 0.0074 miR-423-5p HDL-cholesterol -0.3052 0.1266 -2.41 0.0172 Correlationsadjustedforsex miR-130b-3p HbA1C 0.1903 0.04728 4.03 <.0001 miR-374a-5p HbA1C 0.1763 0.07174 2.46 0.0152 miR-374a-5p HOMA-IR 0.1082 0.04383 2.47 0.0147 miR-374a-5p Fasting-Insulin 0.04138 0.01852 2.23 0.0270 Tocalculatecorrelations,Ctvalueswereconvertedintocopynumbers(10^((Ct-25)/-3,3)*100)totakeintoaccountthelogarithmicscaleofthedata. doi:10.1371/journal.pone.0128372.t003 Fig3.PredictedcellularpathwaysofthetargetgenesofthesignificantlyalteredcirculatingmiRNAs inserumofpre-and/ordiabeticpatientsvscontrols.OnlyvalidatedmiRNAsinthewholecohort wereconsidered. doi:10.1371/journal.pone.0128372.g003 PLOSONE|DOI:10.1371/journal.pone.0128372 May28,2015 9/14 CirculatoryMiRNAsofAsianIndianPhenotype Fig4.CirculatingmiRNAconcentrationsofthe9selectedmiRNAsidentifiedinthediscoverygroup quantifiedintheserumofmicefedwithnormalpelletdiet(NPD;n=5)orwithhighfatdiet(HFD; n=6).Dataareexpressedasarbitraryunits(AU).White,NPDmice;Black,HFD. doi:10.1371/journal.pone.0128372.g004 increasedcirculatingconcentrationsofmiR-128,miR-130b-3p,miR-99b-5p,miR-629a-5pand miR-let-7d-3pexpressioninHFDmicecomparedwithNPDfedmice(p<0.05).Conversely, miR-142-3pwassignificantlylowerinHFDanimalscomparedtocontrolmice(Fig4)Correla- tionsbetweentheexpressionsofalteredmiRs(HFDvsNPD)withthemetabolicparameters werecalculatedandareshowninTable4.Asinhumanpre-diabeticsubjects,miR-128waspos- itivelycorrelatedwithcholesterol. Discussion SouthAsiansarecharacterizedbyauniquemetabolicprofilewithhigherinsulinlevels[3],a greaterdegreeofinsulinresistance[4],greaterabdominaladiposityi.e.,higherwaistcircumfer- encedespitelowerbodymassindex[2]andahigherprevalenceofdiabetes[5].Insulinresis- tancehasbeendemonstratedinAsianIndiansevenduringadolescence[6]and hyperinsulinemiaseemstobepresentinAsianIndiansevenatbirth[7].Itappearsthatsome Table4. CorrelationsbetweencirculatingmiRNAconcentrationsandmetabolicparametersinmice. miRNAs metabolicparameters Estimate StdErr tValue Probt miR-128 cholesterol -0.0292 0.005164 -5.65 0.0005 miR-484 Glucose -0.01151 0.00478 -2.41 0.04 miR-629-5p Glucose 0,04474 0,01286 3,48 0,007 miR-128 Glucose 0,02141 0,00837 2,56 0,031 miR-130b-3p HbA1c -1.2578 0.4202 -2.99 0.019 miR-99b-5p HbA1c -2.4481 0.463 -5.29 0.001 miR-130b-3p HDL -0.03028 0.00876 -3.46 0.011 miR-99b-5p HOMA_IR 0.1122 0.04224 2.66 0.026 miR-let-7d-3p HOMA_IR 0.02725 0.01108 2.46 0.036 miR-99b-5p TGL 0.02065 0.00898 2.3 0.047 miR-let-7d-3p TGL 0.005752 0.00214 2.69 0.025 miR-99b-5p VLDL 0.1033 0.04491 2.3 0.047 miR-let-7d-3p VLDL 0.02876 0.0107 2.69 0.025 doi:10.1371/journal.pone.0128372.t004 PLOSONE|DOI:10.1371/journal.pone.0128372 May28,2015 10/14

Description:
acterized to represent 'Asian Indian phenotype' known to be more prone to develop T2DM .. from the National Institute of Nutrition, Hyderabad, India.
See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.